Country: Netherlands
Language: English
Source: HMA (Heads of Medicines Agencies)
ivermectin 1.55 % w/w, praziquantel 7.75 % w/w
Janssen Animal Health
QP54AA51
Oral paste
ivermectin, combinations
Horses
2011-09-28
Revised: October 2011 AN: 01898/2010 Page 1 of 8 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Furexel Combi Oral Paste 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each syringe contains 7.74 g of paste and delivers: ACTIVE SUBSTANCES: Ivermectin 0.120 g (15.5 mg/g) Praziquantel 0.600 g (77.5 mg/g) EXCIPIENTS: Buthylhydroxyanisole (E320): 0.002g Sunset Yellow (E110): 0.003 g Ttitanium dioxide (E171)): 0.155g For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Oral paste Smooth, homogeneous orange paste 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Horses 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of mixed cestode and nematode or arthropod infestations in horses. The following parasites of horses are sensitive to the antiparasitic effects of the product: Adult Tapeworms: _ANOPLOCEPHALA PERFOLIATA _ _ANOPLOCEPHALA MAGNA_ Large strongyles: _Strongylus vulgaris _(adults and arterial larval stages) _Strongylus edentatus_ (adults and tissue larval stages) _Strongylus equinus _(adults) _Triodontophorus _spp_ _(adults)_ _ _Triodontophorus brevicauda _ Revised: October 2011 AN: 01898/2010 Page 2 of 8 _Triodontophorus serratus _ _Craterostomum acuticaudatum_ (adults) Adult and immature (intraluminal fourth-stage larvae) of small strongyles or cyathostomes, including benzimidazole-resistant strains: _ _ _Coronocyclus_ spp _Coronocyclus coronatus _ _Coronocyclus labiatus _ _Coronocyclus labratus_ _Cyathostomum_ spp _Cyathostomum catinatum _ _Cyathostomum pateratum_ _Cylicocyclus_ spp _Cylicocyclus ash Read the complete document